CRT 2024

NIR Fluorescence Inflammation Imaging for VP and DCB Efficacy

Speaker(s)

• 

  Farouc A. Jaffer, MD, PhD

  Director Coronary Intervention and CTO PCI Program
  Massachusetts General Hospital / Harvard Medical School
  Boston, Massachusetts, United States

  Disclosure(s): Canon, HeartFlow, Siemens, Mercator, Amarin, Neovasc, Teleflex: University Grants/Research Support (Ongoing); DurVena Inc: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Intravascular Imaging Incorporated: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Massachusetts General Hospital: Receipt of Royalties (Ongoing); Medtronic, Fastwave, Intravascular Imaging Inc, Saghmos, DurVena: Consultant (Ongoing)